COVID-19 Treatment: CDSCO shows green flag to Baxter India Oxiris filter
The filter is intended to be used in the critically ill Covid-19 patients in need of blood purification where excessive inflammatory mediators are present, Baxter India said in a statement.;
Advertisement
Gurugram: Healthcare firm Baxter India on Tuesday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for the use of its Oxiris blood purification filter for the treatment of Covid-19 patients.
The filter is intended to be used in the critically ill Covid-19 patients in need of blood purification where excessive inflammatory mediators are present, Baxter India said in a statement.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.